ALIMP — Implanet SA Share News
0.000.00%
Last trade - 00:00- €21.42m
- €25.87m
- €12.47m
Brief: Implanet Sets Up Bond Financing Line
Brief: Implanet H1 Net Loss Narrows To 2.8 Million Euros
Brief: Implanet SA Implanet Opens German Subsidiary
Brief: Implanet H1 Revenue Down At EUR 3.6 Mln
Brief: Implanet Announces Opening Of A United Kingdom Sales Branch
Brief: Implanet launches Jazz Evo For Degenerative Spine Disease In Adults
Brief: Implanet Q1 Revenue Down At 1.9 Million Euros
Brief: Implanet FY Net Loss Narrows At 6.6 Million Euros
Brief: Implanet And L&K Biomed Finalize Partnership With Cross-Distribution Agreements
Brief: Implanet 2017 Revenue Of EUR 7.8 Million
Brief: Implanet Announces Strategic Partnership With L&K BIOMED
Brief: Implanet Transfers Liquidity Contract With Oddo Corporate Finance To Tradition Securities And Futures
Brief: Implanet raises 1.75 million with u.s. Investors
Brief: Implanet announces CE mark clearance for JAZZ Passer
Brief: Implanet Q3 sales rise to 1.8 million euros
Brief: Implanet announces grant of two new patents in the U.S.
Brief: Implanet H1 operating loss narrows to 3.5 million euros
Brief: Implanet receives FDA clearance to market new Jazz Passer
Brief: Implanet announces positive clinical analysis results of JAZZ implants